Unknown

Dataset Information

0

Lamotrigine add-on therapy for drug-resistant focal epilepsy.


ABSTRACT:

SUBMITTER: Panebianco M 

PROVIDER: S-EPMC7083514 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Lamotrigine add-on therapy for drug-resistant focal epilepsy.

Panebianco Mariangela M   Bresnahan Rebecca R   Ramaratnam Sridharan S   Marson Anthony G AG  

The Cochrane database of systematic reviews 20200320


<h4>Background</h4>This is an updated version of the Cochrane Review previously published in 2016. Epilepsy is a common neurological disorder, affecting 0.5% to 1% of the population. For nearly 30% of these people, their epilepsy is resistant to currently available drugs. Pharmacological treatment remains the first choice to control epilepsy. Lamotrigine is one of the newer antiepileptic drugs. Lamotrigine, in combination with other antiepileptic drugs (add-on), can reduce seizures, but with som  ...[more]

Similar Datasets

| S-EPMC8647098 | biostudies-literature
| S-EPMC6614921 | biostudies-literature
| S-EPMC8962962 | biostudies-literature
| S-EPMC7059897 | biostudies-literature
| S-EPMC6517293 | biostudies-literature
| S-EPMC8094401 | biostudies-literature
| S-EPMC7387132 | biostudies-literature
| S-EPMC8919456 | biostudies-literature
| S-EPMC6437881 | biostudies-literature
| S-EPMC6804215 | biostudies-literature